Navigation Links
Closing the gap: Journal launch brings together wound-healing knowledge
Date:10/13/2008

Until now, controversy has existed as to the exact cell type that produces connective tissue growth factor (CTGF), a key protein in the wound healing process. This knowledge gap is closed in a paper featured in the first issue of Fibrogenesis & Tissue Repair, a new open access journal published by BioMed Central.

CTGF is normally induced during tissue repair while elevated, prolonged CTGF expression is the hallmark of fibrosis. In the paper Andrew Leask and his colleagues from the University of Western Ontario, Canada, show that CTGF expression in skin correlates with myofibroblast induction, and that CTGF-expressing pericytes are significant contributors to myofibroblast activity during cutaneous tissue repair. Commenting on the paper, the Editor in Chief of the new journal, Massimo Pinzani, said, "This is a good example of the type of high quality research Fibrogenesis & Tissue Repair will publish. The information provided by this paper is highly relevant to tissue repair and fibrosis in other organs and systems."

Fibroproliferative diseases affecting different organs and systems constitute the largest burden and challenge of modern medicine. Nearly 45% of all deaths in the developed world are caused by chronic inflammatory and fibrogenic disorders such as cardiovascular disease, pulmonary fibrosis, progressive kidney disease, systemic sclerosis, liver cirrhosis and inflammatory bowel disease. Fibrogenesis and Tissue Repair features high-quality studies providing novel insights into the mechanisms, diagnosis and treatment of these and related diseases. It aims to help fill the gap in communication that exists between scientists working in different subspecialties of experimental and clinical medicine and to allow them to rapidly exchange ideas and work on common targets.

Pinzani said, "It is truly exciting to launch an online journal covering the extremely relevant area of tissue fibrosis and repair. The opportunity to address key issues in this area of biology and medicine with a sound inter-disciplinary philosophy will certainly lead to a better communication and, hopefully constructive collaborative efforts, between basic scientists and clinicians involved in the study and the cure of chronic fibrogenic disorders."

The journal's open access nature can only help it in these aims. According to Pinzani "Open access means that high quality research will be freely available to all, without charge, worldwide, and this is definitely a step forward towards a fast and global spread of knowledge."


'/>"/>

Contact: Graeme Baldwin
graeme.baldwin@biomedcentral.com
44-020-707-94804
BioMed Central
Source:Eurekalert

Related biology news :

1. Closing the hydrogen economic loop
2. Closing the gap between fish and land animals
3. A new journal where molecular biology meets clinical research
4. Audience Selected as Silver Winner in This Years Wall Street Journal Technology Innovation Awards and Winner of the Semiconductors Category
5. News from the October 2008 Journal of the American Dietetic Association
6. SAGE-Hindawi launch Journal of Dental Biomechanics
7. The IMF says journal editorial documents dramatic increase in survival since the 1980s
8. AGU journal highlights -- Sept. 3, 2008
9. Highlights from the September 2008 Journal of the American Dietetic Association
10. Journal of Nutrition, Health and Aging to be published by Springer
11. Bringing Martian samples to Earth -- preparations outlined in journal Astrobiology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2016)... June 7, 2016  Syngrafii Inc. and San ... relationship that includes integrating Syngrafii,s patented LongPen™ eSignature ... This collaboration will result in greater convenience for ... union, while maintaining existing document workflow and compliance ... ...
(Date:6/2/2016)...   The Weather Company , an IBM Business (NYSE: ... capability in which consumers will be able to interact with ... via voice or text and receive relevant information about the ... Marketers have long sought an advertising solution that can create ... relevant and valuable; and can scale across millions of interactions ...
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
Breaking Biology News(10 mins):
(Date:12/4/2016)... ... December 03, 2016 , ... ... studies. A microbiome impact grant award has been made to Dr. Renato Polimanti ... smoking and drinking on the oral microbiome. Grant proposals have been vetted by ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... MA to soon resume cervical and lumbar disc production, company President, Jake Lubinski ... surgeons who are implanting the AxioMed disc in Bern, Lucerne, and Zurich to ...
(Date:12/2/2016)... Dec. 2, 2016 Amgen (NASDAQ: AMGN ... announced the submission of a Marketing Authorization Application (MAA) to ... candidate to Avastin ® (bevacizumab). The companies believe this ... EMA. "The submission of ABP 215 to ... expand our oncology portfolio," said Sean E. Harper , ...
(Date:12/2/2016)... ... December 01, 2016 , ... ACEA Biosciences, Inc. announced ... I/II clinical trials for AC0010 at the World Conference on Lung Cancer 2016, taking ... update on the phase I/II clinical trials for AC0010 in patients with advanced non-small ...
Breaking Biology Technology: